FinTech

Bio-Gene Technology: Signs research deal with University of Florida

Bio-Gene Technology Signs research deal with University of Florida

  • Bio-Gene Technology (BGT) signs a research agreement with the University of Florida, advancing its program to phase two
  • The company has previously engaged with researchers at the University to test Qcide and Flavocide against resistant strains of flying insects
  • Phase two will explore synergetic traits which may be evident in combination treatments of Qcide or Flavocide with other compounds
  • The studies are set to commence early next year with reporting planned for early in the second quarter of 2022
  • Bio-GeneTechnology shares are trading 2.56 per cent higher at 20 cents
Previous article
Black Rock Mining: Completes campaign to attract graphite customers
Next article
Suncoast Credit Union: Teams with MX
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

UK Authorities Tighten Regulations on P2P Crypto Trading

New measures aim to enhance security for crypto traders in the peer-to-peer market.Highlights: UK authorities introduce new regulations...
FinTech

Citi Wealth Strengthens Services with New AI-Powered Team Member

Citi Wealth Management introduces advanced AI technology for enhanced client experience.Highlights: Citi Wealth Management has launched a new...
FinTech

Coinbase Lists First GBP Stablecoin, Expanding Market Options

The new stablecoin aims to enhance trading in the UK market.Highlights: Coinbase has launched the first GBP stablecoin.This...
FinTech

Former Royal Mint Executives Secure Backing for Precious Metals Trading Platform

New platform aims to modernize precious metals trading for investors.Highlights: Former Royal Mint executives launch a new trading...